AXGN stock news · Axogen, Inc.

Stories about Axogen, Inc. (AXGN) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for AXGN

Follow Axogen, Inc. (AXGN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Nov 3, 2026, 7:43 AM ET · Paperwork
Axogen, Inc. will take part in two upcoming investor conferences to meet with investors.
Neutral
Axogen scheduled management participation in 2 investor conferences. The notice reports no change to its business, so it does not change the company's outlook.
Oct 23, 2026, 2:09 PM ET · Market
Barclays changes its price goal for Axogen to $50 from $55.
Neutral
Barclays cut its Axogen share target but kept its positive rating. Those mixed views do not clearly change the company's outlook.
Oct 1, 2026, 5:31 PM ET · Market
Axogen, Inc. says it has bought BioCircuit Technologies, Inc.
Neutral
Axogen completed its acquisition of BioCircuit, but the filing gives no purchase price or expected business changes. The deal does not change Axogen's outlook based on the information provided.
Sep 10, 2026, 5:06 PM ET · Market
Axogen, Inc. has signed an important agreement with BioCircuit Technologies.
Neutral
Axogen filed a merger agreement with BioCircuit and a corrected investor presentation; no deal price or financial terms were disclosed, so the filing is neutral for Axogen.
Sep 10, 2026, 6:48 AM ET · Deal
Axogen, Inc. has signed a big deal to merge with BioCircuit Technologies, Inc.
Neutral
Axogen will buy BioCircuit for $200.0 million and is selling shares at $42.50 to fund it; the deal adds products but raises financing and integration concerns.